Γ

SynBioBeta Speaker

Vivek Adarsh

Mithrl

CEO & Co-Founder

Vivek is the CEO and Cofounder of Mithrl, a Series A Applied AI company building the scientific decision engine for biopharma. Their mission is bold and simple: help R&D teams go from idea to IND 50% faster.



Vivek brings a deeply technical background to this work. He holds a PhD in Computer Science, with research focused on reinforcement learning. Before founding Mithrl, he was at NVIDIA, where he contributed to the CUDA compiler. He also was a researcher at HP Labs, where he worked on distributed systems and is a named inventor on multiple patents.



And on a lighter note, as the name Mithrl might suggest, Vivek is a devoted Lord of the Rings fan.

Sessions Featuring

Vivek

This Year

Special Event

12:00 PM

-

1:15 PM

AIxBIO

AI + Biopharma Luncheon

The AI + Biopharma Luncheon at SynBioBeta 2026 brings together innovators working at the intersection of artificial intelligence and life sciences. This gathering offers a chance for founders, researchers, investors, and industry leaders to connect over lunch while exploring how AI is accelerating drug discovery, transforming R&D workflows, and reshaping the future of biopharma. The luncheon will also feature a panel discussion with Vivek Ardash, CEO of Mithrl, and Eric Kauderer-Abrams, Life Sciences at Anthropic, offering perspectives on how frontier AI models, scientific reasoning systems, and new computational tools are beginning to change the way biopharma teams generate insights, design experiments, and move from discovery to development.

Special Event

12:00 PM

-

1:15 PM

AIxBIO

AI + Biopharma Luncheon

The AI + Biopharma Luncheon at SynBioBeta 2026 brings together innovators working at the intersection of artificial intelligence and life sciences. This gathering offers a chance for founders, researchers, investors, and industry leaders to connect over lunch while exploring how AI is accelerating drug discovery, transforming R&D workflows, and reshaping the future of biopharma. The luncheon will also feature a panel discussion with Vivek Ardash, CEO of Mithrl, and Eric Kauderer-Abrams, Life Sciences at Anthropic, offering perspectives on how frontier AI models, scientific reasoning systems, and new computational tools are beginning to change the way biopharma teams generate insights, design experiments, and move from discovery to development.

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include